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Neuroprotective agentBackground and purpose: HSPA12B is a newly discovered member of the Hsp70 family proteins. This study
investigated the effects of HSPA12B on focal cerebral ischemia/reperfusion (I/R) injury in mice. Methods:
Transgenic mice overexpressing human HSPA12B (Tg) and wild-type littermates (WT) were subjected to
60 min of middle cerebral artery occlusion to induce ischemia and followed by reperfusion (I/R). Neurolog-
ical deﬁcits, infarct volumes and neuronal death were examined at 6 and 24 hrs after reperfusion. Blood–
brain-barrier (BBB) integrity and activated cellular signaling were examined at 3 hrs after reperfusion.
Results: After cerebral I/R, Tg mice exhibited improvement in neurological deﬁcits and decrease in infarct vol-
umes, when compared with WT I/R mice. BBB integrity was signiﬁcantly preserved in Tg mice following ce-
rebral I/R. Tg mice also showed signiﬁcant decreases in cell injury and apoptosis in the ischemic hemispheres.
We observed that overexpression of HSPA12B activated PI3K/Akt signaling and suppressed JNK and p38 ac-
tivation following cerebral I/R. Importantly, pharmacological inhibition of PI3K/Akt signaling abrogated the
protection against cerebral I/R injury in Tg mice. Conclusions: The results demonstrate that HSPA12B protects
the brains from focal cerebral I/R injury. The protective effect of HSPA12B is mediated though a PI3K/
Akt-dependent mechanism. Our results suggest that HSPA12B may have a therapeutic potential against is-
chemic stroke.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Ischemic stroke is the leading cause of disability and third in mor-
tality in industrialized nations [1]. A recent report from the American
Heart Association demonstrates that someone has a stroke every
40 seconds and stroke accounted for ≈1 of every 18 deaths in the
United States [2]. Thus, it is a huge need to ﬁnd effective therapeutic
targets for protecting brains from ischemic injury.
Heat shock proteins (HSPs), also called stress proteins, form a het-
erogeneous family of proteins that exhibit a diverse range of protein
chaperoning properties including facilitating protein folding, trafﬁcking
and the removal of aberrant proteins [3,4]. Evidence has implicated
an involvement of certain HSPs in neuronal protection or damage, par-
ticularly in experimental models of cerebral ischemic injury [3–6]. Forod–brain-barrier; HSPs, Heat
; PI3K/Akt, phosphoinositide
m chloride; WM, Wortmannin
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rights reserved.example, the overexpression of HSP70, hemeoxygenase-1 (HSP32)
and HSP27 in transgenic mice has been reported to increase tolerance
to cerebral ischemic challenge [3–7]. In contrast, the targeted disruption
of HSP110/105 gene attenuates cerebral ischemic stress [8].
Heat shock protein A12B (HSPA12B)was discovered in human ath-
erosclerotic lesions by Han et al. in 2003 [9]. Subsequently, two studies
have revealed that HSPA12B is predominantly expressed in endotheli-
al cells and is involved in vascular development in zebraﬁsh [10,11].
We have recently reported that transgenic mice with overexpression
of HSPA12B showed attenuation of cardiac dysfunction during en-
dotoxemia [12]. Interestingly, we observed that cardiac protection
by HSPA12B was mediated by activation of the phosphoinositide
3-kinase/protein kinase B (PI3K/Akt) signaling pathway [12]. Further-
more, activated Akt has been proposed as a mediator for HSPA12B-
induced migration of endothelial cells [10]. However, the role of
HSPA12B in cerebral ischemic injury has not been investigated.
Activation of the PI3K/Akt pathway has been reported to prevent
neuronal apoptosis and protect the brain from cerebral ischemia/
reperfusion (I/R) injury [13–15]. Overexpression of HSPA12B induces
the activation of the PI3K/Akt signaling pathway in the myocardium
of endotoxemic mice [12]. We hypothesized that overexpression of
HSPA12B will protect brain from cerebral ischemic injury through
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have demonstrated that overexpression of HSPA12B signiﬁcantly pro-
tects against cerebral I/R injury. To the best of our knowledge, this is
the ﬁrst demonstration that overexpression of HSPA12B improves
neurological deﬁcits and reduces infarct volumes following cerebral
I/R. This is achieved, at least in part, activation of the PI3K/Akt signal-
ing pathway. Our results indicate that HSPA12B is a novel neuro-
protective heat shock protein that protects against ischemic stroke.
2. Materials and methods
2.1. Antibodies and chemicals
2,3,5-triphenyltetrazolium chloride (TTC), Evan's blue,Wortmannin
(WM), primary antibody for α-Tubulin were purchased from Sigma-
Aldrich (St Louis, MO). Primary antibody for HSPA12B was a generous
gift fromDr. ZhihuaHan (East Tennessee State University) [11]. Primary
antibodies for Akt and phosphor-Akt (p-Akt), Gsk-3β and phosphor-
Gsk-3β (p-Gsk-3β), p38 and phosphor-p38 (p-p38), JNKs and
phosphor-JNKs (p-JNKs), ERKs and phosphor-ERKs (p-ERKs), and
Bcl-2 and Bax were obtained from Cell Signaling Technology (Beverly,
MA). Primary antibody for Angiopoietin-1 (Ang-1) was from Abcam
(Cambridge, UK). Primary antibodies for ZO-1, ZO-2 and Occludin
were from Invitrogen (Camarillo, CA). The TUNEL assay kit was from
Promega (Madison, WI). The LightShift Chemiluminescent EMSA kit
and the supersignal west pico chemiluminescent substrate were
obtained from Pierce (Rockford, IL).
2.2. Animals
The generation of HSPA12B transgenic mice (Tg) has been de-
scribed previously [12]. The human hspa12b transgene consists of
20.4 kb of coding sequence (gene ID: ENSG number 00000132622),
7.3 kb of 5′ ﬂanking sequence and promoter, and 3.6 kb of 3′ ﬂanking
sequence. Mice were housed in the Animal Laboratory Resource Facil-
ity, Model Animal Research Center (MARC) of Nanjing University. All
of the experiments were performed with the guidelines for the “Prin-
ciples of Laboratory Animal Care” and the “Guide for the care and use
of laboratory animals” published by the NIH (NIH Publication No.
85-23, revised 1996). The animal care and experimental protocols
were approved by the Nanjing University Committee on Animal Care.
2.3. Focal cerebral I/R model
Focal cerebral I/R was induced by middle cerebral artery occlusion
(MCAO) as described in our previous studies [13,14,16]. Male Tg and
wild-type (WT) littermates weighing 24 to 26 g at the age of 8 to10
weeks were anesthetized by the inhalation of 1.5–2% isoﬂurane. A 6–0
ﬁlament coated with silicon resin (Doccol Corp.) was introduced into
the left common carotid artery and advanced 11 mm to begin ischemia.
Reperfusion was achieved by removing the ﬁlament after 60 min of oc-
clusion. The successful I/R surgery was veriﬁed and recorded by the
measurement of cerebral blood ﬂow with a laser-Doppler ﬂowmetry
(BPM2 System, Vasamedics Inc., St. Paul, MN) as described in our previ-
ously studies [13]. Body temperature was maintained throughout the
procedure, from the beginning of the surgery until palinesthesia was
observed, at 36.5 to 37.0 °C by means of a lamp and a heating blanket.
Sham-operated mice served as controls.
In PI3K/Akt inhibition experiments, mice were treated with a PI3K
inhibitor WM (100 μM, 4 μl) by intracerebroventricular injection at
ischemic side 1 hr prior to MCAO.
2.4. Measurement of infarct volumes
Infarct Volumesweremeasured at 6 and 24 hrs after I/R. The brains
were harvested and sectioned coronally. The sections were stainedwith 2% TTC for 15 min followed by ﬁxationwith 10% formalin neutral
buffer solution (pH 7.4) [14,16]. The infarct lesions (unstained areas
shown as pale color) were measured using a computerized image
analysis system (AlphaEaseFC). The percent infarction volume over
total brain volumewas calculated as described in our previous studies
[13,14,16].
2.5. Neurological scoring
Neurological score was evaluated at 6 and 24 hrs after I/R. All mice
were scored by a blinded investigator using a neurological evaluation
instrument described in our previous studies [13,14]. In brief, the scor-
ing system included ﬁve principal tasks: spontaneous activity over a
3-min period (0–3), symmetry of movement (0–3), open-ﬁeld path
linearity (0–3), beamwalking on a 3×1-cm beam (0–3), and response
to vibrissae touch (1–3). The scoring system ranged from 0 to 15, in
which 15 is a perfect score and 0 is death due to cerebral I/R injury.
Sham controls received a score of 15 [13,14].
2.6. Histological changes in the hippocampus
The ischemic hemispheres were collected at 24 hrs after I/R and
processed for parafﬁn-sectioning. The sections were subjected to
hematoxylin–eosin (H&E) staining to evaluate the histological changes
in the hippocampus.
2.7. Neuronal apoptosis
The ischemic hemispheres were collected at 6 and 24 hrs after I/R
and processed for parafﬁn-sectioning. Neuronal apoptosis was exam-
ined using a TUNEL assay kit as described in our previous studies [17].
Hoechst 33342 reagent was used to counterstain the nuclei. The num-
ber of TUNEL-positive cells was countedwithinmore than ﬁve random-
ly chosen ﬁelds positioned in the ventral and caudal periinfarct areas
of slices using a ﬂuorescent microscope at a magniﬁcation of 200×
(Zeiss Ltd. German). The percentage of apoptotic cells over total cells
was calculated.
2.8. BBB permeability
BBB permeability was estimated by Evan's blue leakage. Mice were
perfused with Evan's blue dye (2%, 2.5 ml/kg) at the start of reperfu-
sion after ischemia. Three hours after reperfusion, mice were anesthe-
tized and perfused with ice-cold phosphate buffered saline via the
ascending aorta until the perfusion solution was clear from the right
atrium. The brains were then sectioned coronally and photographed.
To quantify the permeability of BBB, the amount of Evan's blue con-
tent wasmeasured in the ischemic hemispheres as reported previous-
ly [14,18]. Brieﬂy, the ischemic hemispheres were homogenized in
2.0 ml saline and centrifuged at 1000×g for 30 min. The supernatants
were collected and mixed with equal volumes of 100% trichloroacetic
acid to precipitate proteins. The supernatants were read photometri-
cally for the absorbance of Evan's blue dye color at 610 nmwith a Syn-
ergy HT plate reader (Bio-Tek, USA). Evan's blue dye content was
calculated based on a standard curve and expressed as ng/mg protein.
2.9. Immunoblotting analysis
The ischemic hemispheres were collected at 3 hrs after I/R. The pro-
tein extracts were prepared for immunoblotting analysis according to
the methods described in our previous studies [12,13]. Brieﬂy, equal
amount of proteins were separated on 10% SDS-PAGE and transferred
onto Immobilon-P membranes (Millipore). The membranes were
probed with appropriate primary antibodies, respectively, followed by
incubation with peroxidase-conjugated secondary antibodies. The sig-
nals were detected by enhanced Pierce chemiluminescence. To control
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Tubulin. The signals were quantiﬁed by scanning densitometry and
the results from each experimental groupwere expressed as relative in-
tegrated intensity compared with that of controls.
2.10. Statistical analysis
Results are expressed as mean±standard deviation (X±SD). Com-
parison analysis between groups was performed using a one-way anal-
ysis of variance (ANOVA). Tukey's procedure for multiple range tests
was performed. Pb0.05 was considered to be signiﬁcant.
3. Results
3.1. HSPA12B overexpression decreases cerebral infarct volumes
following focal cerebral I/R injury
To determine the role of overexpression of HSPA12B in cerebral I/R
injury, we developed transgenic mice with overexpression of human
hspa12b gene [12]. Fig. 1A shows that HSPA12B protein levels were
signiﬁcantly greater by 7.8-fold in the brains of Tg mice than in WT
brains (Pb0.01).
To evaluate whether overexpression of HSPA12B will decrease in-
farct volume following cerebral I/R, Tg mice and age-matched WT mice
were subjected to cerebral ischemia (60 min) followed by reperfusion
up to 24 hrs. The infarct volumes were evaluated. As shown in Fig. 1B,6 hrs
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Fig. 1. Overexpression of HSPA12B attenuated cerebral I/R injury. (A) Increased HSPA12B exp
mice (Tg) (8–10 weeks old). The cellular proteins were prepared for immunoblot analysis o
ing control. Each lane represents an individual mouse. n=4/group, * Pb0.01. (B) Transgeni
were subjected to cerebral I/R. Infarct volumes were evaluated at 6 and 24 hrs after reperf
cerebral volume. n=7–8/group, *Pb0.01 and #Pb0.05. (C) Successful I/R surgery was veriﬁcerebral I/R signiﬁcantly induced infarct volumes by 23.1% at 6 hrs and
by 29.6% at 24 hrs after reperfusion in WT mice. In contrast, the infarct
volumes in Tg mice were signiﬁcantly decreased by 49.7% at 6 hrs
(11.6±2.7% vs. 23.1±4.2%, Pb0.01, F=55.74) and by 47.6% at 24 hrs
(15.5±3.0% vs. 29.6±2.5%, Pb0.01, F=55.74) after cerebral reperfu-
sion, respectively, when compared with WT I/R mice. Fig. 1C shows
that cerebral blood ﬂowwas decreased by >90% immediately following
occlusion ofmiddle cerebral artery and returned to the levels prior to oc-
clusion after cerebral reperfusion, indicating that the cerebral ischemia
followed by reperfusion was performed successfully.3.2. Overexpression of HSPA12B improves neurological deﬁcits following
cerebral I/R injury
We examined whether overexpression of HSPA12B could improve
neurological functional recovery following cerebral I/R injury. Neuro-
logical score evaluation is an index for the degree of neurological deﬁcits
associated with ischemic stroke. Fig. 2 shows that cerebral I/R markedly
caused neurological deﬁcits inWTmice as evidenced by decreased neu-
rological scores by 61.9% at 6 hrs and by 73.3% at 24 hrs after reperfu-
sion compared with WT sham control (Pb0.01, F=14.429). However,
the cerebral I/R-induced decrease in neurological scoreswas signiﬁcant-
ly attenuated by overexpression of HSPA12B. Tg mice showed sig-
niﬁcantly improved neurological scores by 32.5% at 6 hrs and by 65.6%
at 24 hrs after cerebral reperfusion, respectively, when compared withTg
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Fig. 2. Overexpression of HSPA12B improved neurological deﬁcits following cerebral I/R
injury. The neurological scores were evaluated using a scoring system at 6 and 24 hrs
after I/R. The scoring system ranged from 0 to 15, in which 15 is a perfect score and
0 is death due to cerebral I/R injury. n=7–8/group, *Pb0.01 and #Pb0.05.
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neurological scores betweenWT sham and Tg sham controls.
3.3. Overexpression of HSPA12B attenuates cerebral I/R-induced
neuronal damage
We evaluated the effect of overexpression of HSPA12B on neuronal
damage following cerebral I/R. As shown in Fig. 3, cerebral I/R causedHippocam
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after I/R
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Sham
Fig. 3. Overexpression of HSPA12B attenuated neuronal damage in the hippocampus follow
tissue were stained with H&E. The CA1 ﬁeld of hippocampus in WT I/R mice showed extrem
neurons in the CA1 ﬁeld of Tg I/R mice showed less damage. n=5–6 per group.severe neuronal damage in the hippocampus in ischemic hemispheres
of WT mice as characterized by neuronal shrinkage and nuclear
pyknosis. In contrast, there is less neuronal damage and a better pre-
served morphology of the hippocampus in ischemic hemispheres in
Tg mice, when compared with WT-I/R mice.
We also examined the effect of overexpression of HSPA12B on ce-
rebral I/R-induced brain apoptosis. The apoptotic cells were counted
in the ventral and caudal periinfarct areas as indicated in Fig. 4A. As
shown in Fig. 4B, cerebral I/R signiﬁcantly induced cell apoptosis
(20.6% of total cells at 6 hrs and 38.8% of total cells at 24 hrs) in WT
mice comparedwithWT sham control (Pb0.01, F=247.205). Cerebral
I/R also induced cell apoptosis in Tg mice (7.5% of total cells at 6 hrs
and 15.3% of total cells at 24 hrs) compared with Tg sham control
(Pb0.01, F=247.205). However, the apoptotic cells in Tg mice were
signiﬁcant less by 63.5% at 6 hrs and by 60.6% at 24 hrs after cerebral
I/R, when compared with WT I/R mice (Pb0.01, F=247.205).
3.4. Overexpression of HSPA12B reduces blood–brain barrier
permeability following cerebral I/R
A functional BBB plays a critical role in preventing brain injury from
cerebral I/R. We examined the effect of overexpression of HSPA12B on
BBB function following cerebral I/R. The Evans blue dye exudation is
an approach for evaluating BBB permeability.Wemeasured the content
of Evans Blue in the brain tissue at 3 hrs after cerebral I/R. Fig. 5 shows
that cerebral I/R signiﬁcantly increased the content of Evans Blue in thepus CA1
ing cerebral I/R. The brains were harvested at 24 hrs after I/R. Parafﬁn-sections of brain
e changes in the neurons with abnormal nuclei and neuronal shrinkage. In contrast, the
TUNEL Hoechst33342 Merge
WT
Tg
WT
Tg
WT
Tg
Sham
6 hrs 
after I/R
24 hrs 
after I/R
A
B
0
10
20
30
40
50
Sham 6 hrs 24 hrs
TU
NE
L-
po
si
tiv
e 
Ce
lls
 (%
)
WT
Tg
*
*
*
**
*
Fig. 4. Overexpression of HSPA12B attenuated cerebral I/R-induced apoptosis. (A) The apoptotic cells were analyzed in the ventral and caudal periinfarct areas as indicated. (B) The
brains were harvested at 6 and 24 hrs after cerebral I/R. Parafﬁn-sections of brain tissue were prepared. The TUNEL assay was performed to detect apoptotic cells (green).
Hoechst33342 was used to counterstain the nuclei (blue). Arrows indicate the TUNEL-positive cells (merge of green and blue). n=3–4/group, * Pb0.01.
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the ischemic hemispheres of Tg mice following cerebral I/R. However,
the content of Evans Blue dye in the ischemic hemispheres of Tg mice
was signiﬁcant lower than in WT mice (43.6±21.7 ng/mg vs.131.0±
62.5 ng/mg, Pb0.05).W
T
Fig. 5. HSPA12B overexpression protected against cerebral I/R-induced BBB permeability. B
3 hrs after cerebral I/R. The data are expressed as per milligram of brain protein (ng/mg). n3.5. Cerebral I/R-induced decreases in ZO and Ang-1 expression are
attenuated by overexpression of HSPA12B
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membrane protein located speciﬁcally at tight-junctions. Therefore,
these proteins play a critical role in maintaining the function of BBB
[19–22]. We examined whether overexpression of HSPA12B could
regulate the expression of these proteins following cerebral I/R. As
shown in Fig. 6, cerebral I/R signiﬁcantly induced decreases in the levels
of Ang-1 by 75.9%, ZO-1 by 57.6% and ZO-2 by 55.1% in WT mice
(Pb0.01, F=415.275 for Ang-1, F=116.994 for ZO-1, F=135.420 for
ZO-2). Cerebral I/R also decreased the levels of Ang-1, ZO-1 and ZO-2
in the brain tissues of Tgmice comparedwith Tg sham control. Howev-
er, the levels of Ang-1, ZO-1 and ZO-2 in Tg mice were signiﬁcantly
greater by 110.8%, 45.8% and 63.2%, respectively, than that in WT mice
(Pb0.01, F=415.275 for Ang-1, F=116.994 for ZO-1, F=135.420 for
ZO-2). There is no signiﬁcant difference in the levels of Occludin be-
tween WT and Tg mice in the presence and absence of cerebral I/R.
3.6. Overexpression of HSPA12B increases Bcl-2 and decreases Bax levels
in the brain tissues following cerebral I/R
Bcl-2 and Bax arewell known regulators of apoptosis during cerebral
ischemia [23–25]. Bcl-2 is an important anti-apoptotic proteinwhile Bax
is a pro-apoptotic effector. We examined the effect of overexpression of
HSPA12B on Bcl-2 and Bax expression in the ischemic hemispheres fol-
lowing cerebral I/R (Fig. 7). Cerebral I/R signiﬁcantly increased the levels
of Bcl-2 and Bax in both WT and Tg mice, respectively, compared with
sham controls. However, Tg I/R mice showed a signiﬁcant higher level
of Bcl-2 by 63.7% and lower level of Bax by 39.5% than that in WT I/R
mice (Pb0.01, F=79.191 for Bcl-2, F=92.373 for Bax). Furthermore,
the ratio of Bcl-2/Bax inWT I/Rmicewasmarkedly decreased compared
withWT shamcontrol (Pb0.01, F=35.035). In strictly contrast, the ratio
of Bcl-2/Bax in Tg mice was signiﬁcantly greater than in both Tg sham
control and WT I/R mice (Pb0.01, F=35.035).
3.7. Cerebral I/R-increased JNKs and p38 phosphorylation are attenuated
by overexpression of HSPA12B
Activation of both JNKs and p38 contributes to cerebral I/R-induced
apoptosis [26–28]. We evaluated whether overexpression of HSPA12BZO-2
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Fig. 6. Overexpression of HSPA12B attenuated the cerebral I/R-induced decreases in Ang-1,
cerebral I/R. The protein extracts were prepared for immunoblot analysis of Ang-1, ZO-1, ZO-
a loading control. n=4/group, * Pb0.01.will attenuate cerebral I/R-induced phosphorylation of p38 and JNKs
in the brain tissues. Fig. 8 shows that cerebral I/R-induced increase in
the levels of p-p38 and p-JNKs in brain tissues of both WT and Tg
mice, respectively, compared with sham controls (Pb0.01, F=333.284
for p38, F=94.749 for JNKs). However, the increased p38 and JNKs
phosphorylation by cerebral I/R were signiﬁcantly attenuated by 59.4%
and 65.5% in Tg mice, respectively, compared to WT I/R mice (Pb0.01,
F=333.284 for p38, F=94.749 for JNKs). The cerebral I/R also induced
increase in p-ERKs levels in both WT and Tg mice. No signiﬁcant differ-
ence was observed in p-ERKs levels between WT I/R and Tg I/R mice.
There is no signiﬁcant difference in the phosphorylation levels of p38,
ERKs and JNKs between WT sham and Tg sham groups.
3.8. Overexpression of HSPA12B increases Akt and Gsk-3β
phosphorylation in the brain tissues following cerebral I/R
Activation of PI3K/Akt signaling has been demonstrated to protect
against cerebral I/R injury [13–15]. We examined whether over-
expression of HSPA12B could activate the PI3K/Akt signaling pathway
following cerebral I/R. As shown in Fig. 9, cerebral I/R markedly in-
creased the levels of p-Akt by 46.5% and p-Gsk-3β by 228.3% in WT
mice (Pb0.01, F=65.828 for p-Akt and F=83.662 for p-Gsk-3β). In-
terestingly, Tg mice exhibited signiﬁcant increased levels of p-Akt by
139.7% and p-Gsk-3β by 554.5% after cerebral I/R (Pb0.01, F=65.828
for p-Akt and F=83.662 for p-Gsk-3β). Thus, overexpression of
HSPA12B increased the levels of p-Akt by 59.7% and p-Gsk-3β by
114.4% in the brain tissues following cerebral I/R, when compared
with WT I/R mice (Pb0.01, F=65.828 for p-Akt and F=83.662 for
p-Gsk-3β).
3.9. PI3K inhibition abolishes protection against cerebral I/R injury by
overexpression of HSPA12B
To determine the role of activation of PI3K/Akt signaling in HSPA12B
overexpression-induced protection against cerebral I/R injury, we
pretreated Tg and WT mice with WM (a selective inhibitor for PI3K)
1 hr prior to cerebral ischemia. The infarct volumes were evaluated
at 6 hrs after reperfusion. Fig. 10A shows that WM administrationOccludin
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Fig. 7. Overexpression of HSPA12B increased Bcl-2 and decreased Bax levels in the brain tissues following cerebral I/R. The ischemic hemispheres were harvested at 3 hrs after I/R.
The cellular proteins were prepared for immunoblot analysis with speciﬁc antibodies. The same membranes were blotted against α-Tubulin to serve as a loading control. n=6/
group. * Pb0.01.
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cerebral I/R injury. The infarct volumes were signiﬁcantly greater in
WM-treated Tg I/Rmice comparedwith Tg I/Rmice that did not receive
WM (Pb0.01, F=31.780). There was no signiﬁcant difference in the in-
farct volumes between Tg I/R and WT I/R mice in the presence of WM
(26.9±4.3% vs. 27.6±2.8%, P>0.05, F=31.780).
PI3K inhibition with WM abolished the overexpression of HSPA12B-
induced signiﬁcant improvement of neurological scores following cere-
bral I/R. As shown in Fig. 10B, the neurological scores at 6 hrs after re-
perfusion were signiﬁcantly decreased in WM-treated Tg I/R mice
comparedwith Tg I/Rmice that did not receiveWM. Therewasno signif-
icant difference in the neurological scores between Tg I/R and WT I/R
mice in the presence ofWM(4.7±1.0 vs. 4.5±0.5, P>0.05, F=33.473).WT Tg WT Tg
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* Pb0.01.Fig. 10C shows that WM administration prevented the overex-
pression of HSPA12B-induced increases in p-Akt and p-Gsk-3β levels
after cerebral I/R. There was no signiﬁcant difference in the levels of
p-Akt and p-Gsk-3β between Tg I/R and WT I/R mice in the presence
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4. Discussion
The present study demonstrated that transgenic mice with over-
expression of HSPA12B showed signiﬁcant attenuation of cerebral I/R
injury as indicated by decreased infarct volumes and improved neuro-
logical deﬁcits. HSPA12B overexpression markedly increased the levelss /JNKs
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bral I/R. Importantly, PI3K inhibition abrogated the overexpression of
HSPA12B-induced protection against cerebral I/R injury. We conclude
that the neuroprotection by overexpression of HSPA12B is mediated,
at least in part, through activation of the PI3K/Akt signaling pathway.
HSPA12B is a newly discovered heat shock protein that belongs
to HSP70 family [9–12]. It is well known that the most heat shock
proteins (HSPs), such as HSP72, HSP25 and αBC, are expressed in dif-
ferent cell types. However, published literatures indicate that the ex-
pression pattern of HSPA12B is different from other HSPs. Using
Northern blot and in situ hybridization methods, Han et al. have dem-
onstrated that HSPA12B is speciﬁcally expressed in blood vessels of
brain, heart, adipose and aorta [9]. Furthermore, Hu et al. have clariﬁed
that HSPA12B is a highly endothelial-cell-speciﬁc distant member of
the HSP70 family [10].We have also demonstrated that the expression
of HSPA12B is colocalized with PCAM-1, a selective marker of endo-
thelial cells. Therefore, HSPA12B is an endothelial cell-speciﬁcally
expressed heat shock protein. Recent studies have shown that some
HSPs, including inducible HSP70, HSP27, HSP32 and HSP20, exert
neuroprotective properties in cerebral ischemic injury [3,5–8]. We
have found in the present study that HSPA12B plays a protective role
in cerebral I/R injury. Transgenic mice showed that overexpression
of HSPA12B signiﬁcantly attenuated cerebral I/R-induced infarct vol-
umes, blood–brain barrier permeability and neuronal apoptosis, sug-
gesting that HSPA12B promotes cell survival following cerebral I/R.
Indeed, previous studies have reported that the presence of HSPA12B
is an essential for the proliferation and migration of human umbilical
vein endothelial cells and vascular development in zebraﬁsh [10,11].
We have previously demonstrated that overexpression of HSPA12B sig-
niﬁcantly prevents sepsis-induced cardiac dysfunction [12]. However,
the role of HSPA12B in the protection against organs ischemic injury,
such as cerebrovascular disorder, has not been explored. In the present
study, we demonstrated that the overexpression of HSPA12B improves
neurological deﬁcits and reduces cerebral infarct volumes after focal ce-
rebral I/R. Our data provide further insight into the biological roles of
HSPA12B in pathophysiologic conditions and indicates that HSPA12B
could be a novel neuroprotective heat shock protein for the manage-
ment and treatment of ischemic stroke.
In the present study, we observed that overexpression of HSPA12B
attenuates cerebral I/R-induced BBB damage. Previous studies haveshown that cerebral I/R causes disruption of the BBBwhich accelerates
the development of abnormal vascular permeability, exacerbates the
initial and post-ischemic injury and clinical symptoms [18,29]. In con-
trast, maintaining the integrity of BBB has been reported to decrease
neuronal damage [14,19,29]. Therefore, protection of the BBB has be-
come an important target of ischemic stroke intervention. The BBB is
the interface between the peripheral circulation and the central ner-
vous system (CNS) which restricts the free molecular exchange be-
tween blood and CNS. This restriction protects CNS from harmful
components of the blood and allows the uptake of essential molecules.
We have observed that overexpression of HSPA12B attenuated the
increased BBB permeability induced by cerebral I/R as evidenced by
reduced Evans Blue leakage into ischemic hemispheres in HSPA12B
Tg mice. The data suggests that overexpression of HSPA12B induced
a protective effect, in part, by preserving BBB integrity after cerebral
I/R.
It is well known that the anatomical substrate of the BBB is the
cerebral microvascular endothelial cells. The continuous layer of cere-
brovascular endothelial cells is connected by tight-junctions which
are an intricate complex of tight-junction proteins, such as zonula
occludens and Occludin. The degradation of tight-junction proteins, in-
cluding ZO-1 and ZO-2, has been shown to be a decisive step for BBB
disruption during ischemic stroke [21,22]. In the present study, we ob-
served that overexpression of HSPA12B signiﬁcantly attenuated cere-
bral I/R-induced decreases in the levels of ZO-1 and ZO-2 in the brain
tissues. We also observed that HSPA12B overexpression signiﬁcantly
increased the levels of Ang-1 in the brain tissues following I/R. Ang-1
is a strong anti-permeability factor that can reduce vascular leakage
through upregulation of ZO-1 and ZO-2 expression [19,20,30,31]. Ang-1
has also been reported to play an important role in limiting the BBB
permeability [19,20,32]. It is possible that overexpression of HSPA12B at-
tenuated cerebral I/R-induced BBB permeability is mediated, in part, by
upregulation of Ang-1 expression.
It has been well documented that apoptosis contributes to the cere-
bral I/R injury [13,28,31].We observed that I/R-induced increase in brain
apoptosis was signiﬁcantly attenuated in HSPA12B Tg mice, suggesting
that overexpression of HSPA12B prevents against cerebral I/R-induced
apoptosis in ischemic brain. To better understand the mechanisms by
which overexpression of HSPA12B attenuates I/R-induce apoptosis,
we examined the activation levels of mitogen-activated protein kinases
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uated the cerebral I/R-induced increases in the levels of phosphorylated
JNKs and p38 in the brain tissues. Increasing evidence has shown that
activation of MAPKs, including JNKs and p38, results in neuronal death
following cerebral I/R injury [26,28], while inhibition of JNK and p38
activation decreased neuronal apoptosis following cerebral I/R injury
[22,33,34]. Our data suggest that anti-apoptotic effect of overexpression
of HSPA12B is mediated, in part, by downregulation of MAPK activation
during cerebral I/R. In addition, we have shown that overexpression of
HSPA12B signiﬁcantly increased the levels of Bcl-2 and the ratio of
Bcl-2/Bax in the brain tissues following I/R. Collectively, our results sug-
gest that HSPA12B decreased cerebral I/R-induced apoptosis by sup-
pressing the activation of JNKs and p38 and upregulating the levels of
Bcl-2.
We and others have demonstrated that activation of PI3K/Akt signal-
ing protects brain from cerebral I/R injury [13–15,35]. We have recent-
ly reported that overexpression of HSPA12B prevents sepsis-inducedcardiac dysfunctionwhich ismediated via activation of PI3K/Akt signaling
[12]. Furthermore, the HSPA12B-induced migration of endothelial cells
is relatedwith the activation of Akt-dependentmechanism [10]. To inves-
tigatewhether activation of the PI3K/Akt signaling pathwaywas involved
in HSPA12B-induced neuroprotection, we examined the phosphoryla-
tion levels of Akt and Gsk-3β in the brain tissues following cerebral I/R.
We observed that HSPA12B overexpression signiﬁcantly increased the
levels of phosphorylated Akt andGsk-3β in ischemic hemispheres. To de-
termine the role of activation of PI3K/Akt signaling by overexpression of
HSPA12B in cerebral I/R injury,we administratedWM, a PI3K selective in-
hibitor, to HSPA12B Tg and WT mice 1 hr prior to cerebral ischemia. We
observed that WM administration completely abrogated the protective
effect of HSPA12B on I/R-induced cerebral injury. Our results suggest
that HSPA12B-induced neuroprotection against cerebral I/R injury is me-
diated through a PI3K/Akt-dependent mechanisms.
The most factors that activate PI3K include growth factors, such as
Ang-1 and VEGF. Ang-1 binds with its receptor, Tie2 on the cell surface,
66 Y. Ma et al. / Biochimica et Biophysica Acta 1832 (2013) 57–66resulting in activation of the PI3K/Akt signaling pathway in Neural
cell, endothelial cells, myocytes and mesenchymal stem cells [36–38].
Indeed, we observed in the present study that overexpression of
HSPA12B increases the expression of Ang-1 in the cerebral tissues
after cerebral I/R. In supporting this, we have reported previously that
overexpression of HSPA12B increases the expression of Ang-1 in the
myocardium during endotoxemia [12]. Therefore, it is possible that
overexpression of HSPA12B activates PI3K/Akt signaling via upreg-
ulation of Ang-1 expression.
In summary, the present study has demonstrated that overex-
pression of HSPA12B protects brain from focal cerebral I/R injury.
The protective effect of HSPA12B is mediated though a PI3K/Akt-
dependent mechanism. Our results suggest that HSPA12B may have
a therapeutic potential against ischemic stroke.
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